Longevity Health Holdings Inc. (XAGE) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Pittsburgh, PA, United States. El CEO actual es J. Ram Ajjarapu.
XAGE tiene fecha de IPO 2021-09-23, 15 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $528.95K.
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
